Tripartite Therapeutics Inc. (TPEX:7920)

Taiwan · Delayed Price · Currency is TWD

8.33

-0.57 (-6.40%)

At close: Jul 29, 2026

8.89% (1Y)

Market Cap	5.92B
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	593.99M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,310,823
Open	8.90
Previous Close	8.90
Day's Range	7.67 - 9.03
52-Week Range	5.91 - 20.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Tripartite Therapeutics

Tripartite Therapeutics Inc. engages in the development of proprietary platform technologies for targeted delivery of therapeutics in Taiwan. Its proprietary OmniLink technology, helps in the therapeutic potential of active pharmaceutical ingredients that were previously limited by toxicities, in vivo stabilities, and unfavorable pharmacokinetic profiles. The company aims to generate a pipeline of treatments for cancer tumors, unmet medical needs in oncology, metabolic diseases, vaccines, and other disease indications. The company was founded i... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 2009

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 7920

Full Company Profile